BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Mesenchymal Stem Cells Surpass Hematopoietic Stem Cells in the Scientific Literature
Comparison of Stem Cell Scientific Publication Rates, by Stem Cell Type

Mesenchymal Stem Cells Surpass Hematopoietic Stem Cells in the Scientific Literature

February 9, 2016 By Cade Hildreth (CEO) 1 Comment

Five of the most commonly used stem cell types that are used for research purposes are embryonic stem cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells, and induced pluripotent stem cells.

Discover class-defining bioproduction tools.

Therefore, the analysis below considers trends in scientific publication rates for these five stem cell types, over a trailing five-year history. PubMed.gov scientific publication rate data is used for this analysis because of its comprehensive nature.1

PubMed is a service of the U.S. National Library of Medicine and the National Institutes of Health (NIH) that includes over 19 million citations from MEDLINE and other life science journals that date back to the 1950s.2 It is the leading search engine through which to search scientific publications, as NIH researchers are mandated by law to submit their research and most external research is submitted as well, either voluntarily or by mandate.3

bitbio

TABLE. Comparison of Stem Cell Publication Rates, by Stem Cell Type (Five-Year Historical)
TABLE. Comparison of Stem Cell Publication Rates, by Stem Cell Type (Five-Year Historical)

Year-Over-Year Comparison of Stem Cell Scientific Publications, by Stem Cell Type

Comparison of Stem Cell Research Frequency, by Stem Cell Type

As observed in the graph above, hematopoietic stem cells were the most frequent type of stem cells to be cited in the scientific literature through 2014. Mesenchymal stem cells were the second most common stem cell type through 2014.

iPSC-derived cardiomyocte therapy

In 2015, mesenchymal stem cells surpassed hematopoietic stem cells to become the most common stem cell type to appear within the scientific literature.

Pluristyx

This is the first time in history that mesenchymal stem cells substantially outpaced hematopoietic stem cells within the scientific literature.

Additionally, mesenchymal stem cells are the only stem cell type of the five analyzed that had an increase in scientific publications from 2014 to 2015.

All four of the other stem cell types decreased in scientific publication frequency during that period.

Embryonic stem cell research came in third place among the five stem cell types that were analyzed, while neural stem cells and induced pluripotent stem cells both showed lower rates of scientific publications over a trailing five-year period.

Footnotes: 
1Source: Pubmed, http://www.ncbi.nlm.nih.gov/pubmed/. Search Terms: 1) “Embyronic Stem Cell” OR “Embryonic Stem Cells”; 2) “Mesenchymal Stem Cell” OR “Mesenchymal Stem Cells”; 3) “Hematopoietic Stem Cell” OR “Hematopoietic Stem Cells”; 4) “Neural Stem Cell” OR “Neural Stem Cells”; 5) “Induced Pluripotent Stem Cell” OR “Induced Pluripotent Stem Cell” OR “iPSC” OR “iPSCs”. Search Executed: January 24, 2106.
2Ncbi.nlm.nih.gov. 2014. Home – PubMed – NCBI. Available at: http://www.ncbi.nlm.nih.gov/pubmed/. Web . 29 Jan. 2016.
3Science Codex. Available at: http://www.sciencecodex.com/public_access _mandate_made_law. Web. 29 Jan. 2016.

5/5 - (3 votes)

Filed Under: HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: MEDLINE, NIH, PubMed, stem cells, US National Library of Medicine

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Comments

  1. Prof.Dr. Albert Ramon says

    August 2, 2016 at 3:31 am

    Dear Cade, again I never seen suches complete work concerning therapeutic overviews , congratulations to BIOINFORMANT . Excellent work

    Reply

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

PolarityTE RMAT

PolarityTE Announces FDA RMAT Awarded to Its Designation Granted to SkinTE®

Advanced Therapy | What is a RMAT Designation (and Who Has One)?

What Is An RMAT? List of Publicly Announced RMAT Designations (64)

i-peaces-cell-manufacturing

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.